AlloStem Therapeutics Secures $75,000 New Round

  • Feed Type
  • Date
    3/31/2011
  • Company Name
    AlloStem Therapeutics
  • Mailing Address
    400 Farmington Avenue Farmington, CT 06032
  • Company Description
    AlloStem Therapeutics was formed to develop, and out-license, a novel class of MEK inhibitors represented by the lead compound CIP-1374.
  • Website
    http://www.allostem.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $75,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Connecticut Innovations

By posting a comment, you agree to our terms and conditions.